🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Several experts said the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

According to the social media company, the platform has removed problematic content and prohibited related keywords and search suggestions. The company stated it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also found communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram said it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they can’t verify. Although the science behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may expose users to potentially serious health risks”.